Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors

PURPOSE: To determine the duration of antimuscarinic therapy for overactive bladder syndrome (OAB) appropriate for assessment of the efficacy of treatment, and to evaluate the possible predictive factors for response to therapy. METHODS: All OAB patients who visited a urology outpatient clinic of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Sheng-Mou, Liao, Chun-Hou, Lin, Ho-Hsiung, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582089/
https://www.ncbi.nlm.nih.gov/pubmed/26620899
http://dx.doi.org/10.5213/inj.2015.19.3.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582089/
https://www.ncbi.nlm.nih.gov/pubmed/26620899
http://dx.doi.org/10.5213/inj.2015.19.3.171

Ejemplares similares